KSM-66 vs Sensoril: Which Ashwagandha Extract Is Better?

Our knowledge-base entry on ashwagandha describes it as one of the best-studied adaptogens — but that general reputation mostly applies to two specific, standardized extracts: KSM-66 and Sensoril. These two brand names, not generic 'ashwagandha' of unclear origin, are behind most of the clinical trials cited in popular articles and on supplement labels. The problem is that a shopper reading 'root extract standardized to 5% withanolides' on a package rarely knows that the same number, measured by a different lab method, can describe a product with a completely different activity profile than the one in the study the advertising cites.

KSM-66 and Sensoril are today's two most common, branded ashwagandha extracts on the supplement market — each patented, made by a different company, each with its own separate body of manufacturer-funded clinical research. They are not synonyms or variants of the same product, and no direct head-to-head trial has ever compared them in a single experiment on the same group of people — everything we know about the differences between them comes from separate studies run independently of each other, which matters for interpreting the results, as we discuss in the limitations section below.

KSM-66, made by the Indian company Ixoreal Biomed, is an extract from the root of Withania somnifera only, produced by water extraction (no alcohol or chemical solvents), with no leaves or other plant parts added. The manufacturer emphasizes that this approach is closer to the traditional Ayurvedic use of the root, and standardizes the product to a minimum of 5% withanolides, measured by a combined spectrophotometric method that includes withanolide glycosides.

Sensoril, patented by the American company Natreon, is instead an extract from both the root and the leaves of the plant together, standardized to a higher declared withanolide content — usually listed as roughly 8–10%. The leaf addition isn't incidental: the leaves of Withania somnifera contain a somewhat different withanolide profile than the root, including a relatively higher share of withaferin A — a compound studied for stronger calming and anti-inflammatory activity than other withanolides. This physical difference in raw material, rather than marketing, is the most likely explanation for why Sensoril tends to be associated with a more pronounced relaxing and sleep-supporting effect in clinical trials than KSM-66.

The most frequently cited study of a high-concentration, full-spectrum root extract of ashwagandha — supplied by the maker of KSM-66 and widely identified with that specific extract in later literature — is the randomized, double-blind, placebo-controlled trial by Chandrasekhar et al. from 2012.

What matters for this comparison: the trial ran for 60 days, used a root-only extract exclusively, and the total dose was 600 mg/day split into two servings. It's this specific regimen — not 'ashwagandha' in general at any dose — that underlies today's popular recommendation of 300 mg twice daily, which you'll see on labels of KSM-66 products.

The key study of a root-and-leaf ashwagandha extract identified in the literature and in materials from manufacturer Natreon as Sensoril is the Auddy et al. trial from 2008 — published in the Journal of the American Nutraceutical Association, a journal that, unlike the Indian Journal of Psychological Medicine, is not indexed in PubMed, which is itself a notable difference in availability and independent verifiability between these two studies.

Two things set this study design apart from the KSM-66 trial: first, several doses were tested at once, which made it possible to show a dose-response relationship — something the Chandrasekhar trial, using a single fixed dose, couldn't assess. Second, the lowest effective dose in the Sensoril trial (125 mg/day) is many times lower than the 600 mg/day tested for KSM-66, which partly reflects Sensoril's higher standardized withanolide content, but shouldn't be read as straightforward proof that Sensoril is 'stronger' — these are two different active compound profiles in different proportions, not the same substance at a different strength.

This is the most important, most often overlooked detail in this comparison: '% withanolides' isn't one universal, standardized measurement the way the concentration of a pure chemical compound would be. In practice, manufacturers can measure withanolide content using different analytical methods — some count only free withanolides, others also include withanolide glycosides (sugar-bound forms), and the results of these methods aren't directly comparable as numbers. That means a declared '5% withanolides' in one product and '8%' in another don't necessarily correspond to a 5:8 difference in the actual, biologically active dose.

An added complication is that, besides KSM-66 and Sensoril, the market is full of generic, unbranded ashwagandha extracts claiming similar or higher withanolide percentages with no clearly described measurement methodology and no clinical trial of their own behind them — they simply ride on ashwagandha's general reputation as a plant, piggybacking on research done for an entirely different, branded extract. A buyer picking up a product labeled only 'ashwagandha root extract, 5% withanolides,' with no KSM-66, Sensoril, or other recognizable brand name, has in practice no guarantee they're buying the substance studied in either trial described above.

It's also worth noting that the Auddy et al. study isn't indexed in PubMed, which makes independent, secondary verification harder compared with the Chandrasekhar et al. study, published in a journal that is in that database. This doesn't invalidate the results, but it's an additional reason for some caution with hard numerical comparisons between these two extracts.

For someone looking for general, well-studied support in managing chronic stress, without a specific focus on sleep, KSM-66 remains a reasonable default choice — mainly because of the broadest, most varied clinical research base among the available branded extracts. Sensoril takes the lead where evening relaxation and sleep support is the priority, though it's worth remembering that conclusion rests on separate studies, not a direct comparison.